• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊马替尼处理的K562细胞中细胞周期基因的差异表达和可变剪接

Differential expression and alternative splicing of cell cycle genes in imatinib-treated K562 cells.

作者信息

Liu Jing, Lin Jin, Huang Lin-Feng, Huang Bo, Xu Yan-Mei, Li Jing, Wang Yan, Zhang Jing, Yang Wei-Ming, Min Qing-Hua, Wang Xiao-Zhong

机构信息

Department of Clinical Laboratory, The Second Affiliated Hospital of Nanchang University, No. 1 Min De Road, Nanchang, 330006, China.

Department of Clinical Laboratory, The First Affiliated Hospital of Nanchang University, Nanchang, 330006, China.

出版信息

Tumour Biol. 2015 Sep;36(10):8127-36. doi: 10.1007/s13277-015-3493-0. Epub 2015 May 17.

DOI:10.1007/s13277-015-3493-0
PMID:25983000
Abstract

Cancer progression often involves the disorder of the cell cycle, and a number of effective chemotherapeutic drugs have been shown to induce cell cycle arrest. The purpose of this study was to comprehensively investigate the effects of imatinib on the expression profile of cell cycle genes in the chronic myeloid leukemia (CML) K562 cell line. In addition, we also investigated alternative splicing of the cell cycle genes affected by imatinib, since an important relationship has been shown to exist between RNA splicing and cell cycle progression. Exon array analysis was performed using total RNA purified from normal and imatinib-treated K562 cells. We identified 185 differentially expressed genes and 277 alternative splicing events between the two cell groups. A detailed analysis by reverse transcription-PCR (RT-PCR) of key genes confirmed the experimental results of the exon array. These results suggested that treatment of K562 cells with imatinib shifts the expression and alternative splicing profiles of several cell cycle-related genes. Importantly, these findings may help improve imatinib treatment strategies in patients with CML and may be useful for imatinib resistance research and CML drug development.

摘要

癌症进展通常涉及细胞周期紊乱,并且已证明多种有效的化疗药物可诱导细胞周期停滞。本研究的目的是全面研究伊马替尼对慢性髓性白血病(CML)K562细胞系中细胞周期基因表达谱的影响。此外,我们还研究了受伊马替尼影响的细胞周期基因的可变剪接,因为已证明RNA剪接与细胞周期进程之间存在重要关系。使用从正常和伊马替尼处理的K562细胞中纯化的总RNA进行外显子阵列分析。我们在两个细胞组之间鉴定出185个差异表达基因和277个可变剪接事件。通过逆转录PCR(RT-PCR)对关键基因进行的详细分析证实了外显子阵列的实验结果。这些结果表明,用伊马替尼处理K562细胞会改变几个细胞周期相关基因的表达和可变剪接谱。重要的是,这些发现可能有助于改善CML患者的伊马替尼治疗策略,并且可能对伊马替尼耐药性研究和CML药物开发有用。

相似文献

1
Differential expression and alternative splicing of cell cycle genes in imatinib-treated K562 cells.伊马替尼处理的K562细胞中细胞周期基因的差异表达和可变剪接
Tumour Biol. 2015 Sep;36(10):8127-36. doi: 10.1007/s13277-015-3493-0. Epub 2015 May 17.
2
A molecular and biophysical comparison of macromolecular changes in imatinib-sensitive and imatinib-resistant K562 cells exposed to ponatinib.对暴露于波纳替尼的伊马替尼敏感和伊马替尼耐药K562细胞中大分子变化的分子和生物物理比较
Tumour Biol. 2016 Feb;37(2):2365-78. doi: 10.1007/s13277-015-4015-9. Epub 2015 Sep 15.
3
miR-101 sensitizes K562 cell line to imatinib through Jak2 downregulation and inhibition of NF-κB target genes.微小RNA-101通过下调Jak2和抑制核因子κB靶基因使K562细胞系对伊马替尼敏感。
Tumour Biol. 2016 Oct;37(10):14117-14128. doi: 10.1007/s13277-016-5205-9. Epub 2016 Aug 12.
4
Use of deferasirox, an iron chelator, to overcome imatinib resistance of chronic myeloid leukemia cells.使用铁螯合剂地拉罗司克服慢性髓性白血病细胞对伊马替尼的耐药性。
Korean J Intern Med. 2016 Mar;31(2):357-66. doi: 10.3904/kjim.2015.024. Epub 2016 Feb 15.
5
MicroRNA-1301-Mediated RanGAP1 Downregulation Induces BCR-ABL Nuclear Entrapment to Enhance Imatinib Efficacy in Chronic Myeloid Leukemia Cells.微小RNA-1301介导的RanGAP1下调诱导BCR-ABL核内滞留以增强伊马替尼在慢性髓性白血病细胞中的疗效。
PLoS One. 2016 May 26;11(5):e0156260. doi: 10.1371/journal.pone.0156260. eCollection 2016.
6
The antiproliferation effect of berbamine on k562 resistant cells by inhibiting NF-kappaB pathway.小檗胺通过抑制NF-κB信号通路对K562耐药细胞发挥抗增殖作用。
Anat Rec (Hoboken). 2009 Jul;292(7):945-50. doi: 10.1002/ar.20924.
7
Biochemical and chemical characterization of Cynara cardunculus L. extract and its potential use as co-adjuvant therapy of chronic myeloid leukemia.水飞蓟素(Cynara cardunculus L. extract)的生化和化学特性及其作为慢性髓细胞性白血病协同辅助治疗的潜在用途。
J Ethnopharmacol. 2017 Apr 18;202:184-191. doi: 10.1016/j.jep.2017.03.026. Epub 2017 Mar 18.
8
[Effect of cryptotanshinone on imatinib sensitivity and P-glycoprotein expression of chronic myeloid leukemia cells].隐丹参酮对慢性髓性白血病细胞伊马替尼敏感性及P-糖蛋白表达的影响
Zhongguo Zhong Yao Za Zhi. 2015 Jun;40(12):2389-95.
9
Alternative splicing of apoptosis-related genes in imatinib-treated K562 cells identified by exon array analysis.外显子芯片分析鉴定伊马替尼处理的 K562 细胞中凋亡相关基因的可变剪接。
Int J Mol Med. 2012 Apr;29(4):690-8. doi: 10.3892/ijmm.2011.872. Epub 2011 Dec 29.
10
Polo-like kinase 1 (Plk1) as a novel drug target in chronic myeloid leukemia: overriding imatinib resistance with the Plk1 inhibitor BI 2536.Polo-like 激酶 1(Plk1)作为慢性髓性白血病的一个新的药物靶点:用 Plk1 抑制剂 BI 2536 克服伊马替尼耐药性。
Cancer Res. 2010 Feb 15;70(4):1513-23. doi: 10.1158/0008-5472.CAN-09-2181. Epub 2010 Feb 9.

本文引用的文献

1
Chemical dissection of the cell cycle: probes for cell biology and anti-cancer drug development.细胞周期的化学剖析:用于细胞生物学和抗癌药物研发的探针
Cell Death Dis. 2014 Oct 16;5(10):e1462. doi: 10.1038/cddis.2014.420.
2
Aberrant expression of splicing factors in newly diagnosed acute myeloid leukemia.新诊断急性髓系白血病中剪接因子的异常表达。
Onkologie. 2012;35(6):335-40. doi: 10.1159/000338941. Epub 2012 May 22.
3
Small molecule amiloride modulates oncogenic RNA alternative splicing to devitalize human cancer cells.小分子氨苯蝶啶调节致癌 RNA 可变剪接以灭活人类癌细胞。
PLoS One. 2011;6(6):e18643. doi: 10.1371/journal.pone.0018643. Epub 2011 Jun 9.
4
Alternative splicing of SYK regulates mitosis and cell survival.SYK 的可变剪接调控有丝分裂和细胞存活。
Nat Struct Mol Biol. 2011 Jun;18(6):673-9. doi: 10.1038/nsmb.2040. Epub 2011 May 8.
5
SON controls cell-cycle progression by coordinated regulation of RNA splicing.SON 通过协调调控 RNA 剪接控制细胞周期进程。
Mol Cell. 2011 Apr 22;42(2):185-98. doi: 10.1016/j.molcel.2011.03.014.
6
Use of serial analysis of gene expression to reveal the specific regulation of gene expression profile in asthmatic rats treated by acupuncture.运用基因表达系列分析揭示针刺治疗哮喘大鼠基因表达谱的特异性调控。
J Biomed Sci. 2009 May 6;16(1):46. doi: 10.1186/1423-0127-16-46.
7
easyExon--a Java-based GUI tool for processing and visualization of Affymetrix exon array data.easyExon——一款基于Java的图形用户界面工具,用于处理和可视化Affymetrix外显子芯片数据。
BMC Bioinformatics. 2008 Oct 14;9:432. doi: 10.1186/1471-2105-9-432.
8
Imatinib (STI571) inhibits DNA repair in human leukemia oncogenic tyrosine kinase-expressing cells.伊马替尼(STI571)抑制表达人白血病致癌性酪氨酸激酶的细胞中的DNA修复。
Z Naturforsch C J Biosci. 2006 Nov-Dec;61(11-12):896-902. doi: 10.1515/znc-2006-11-1219.
9
Coordination of intrinsic, extrinsic, and endoplasmic reticulum-mediated apoptosis by imatinib mesylate combined with arsenic trioxide in chronic myeloid leukemia.甲磺酸伊马替尼联合三氧化二砷对慢性髓性白血病内在、外在及内质网介导凋亡的协同作用
Blood. 2006 Feb 15;107(4):1582-90. doi: 10.1182/blood-2005-06-2318. Epub 2005 Oct 25.
10
Imatinib mesylate (Gleevec) downregulates telomerase activity and inhibits proliferation in telomerase-expressing cell lines.甲磺酸伊马替尼(格列卫)可下调端粒酶活性,并抑制端粒酶表达细胞系的增殖。
Br J Cancer. 2005 May 23;92(10):1881-91. doi: 10.1038/sj.bjc.6602592.